Bruce & Co
Latest statistics and disclosures from Bruce & Co's latest quarterly 13F-HR filing:
- Top 5 stock holdings are UHAL.B, ALL, ABBV, NextEra Energy, Merck & Co, and represent 39.58% of Bruce & Co's stock portfolio.
- Added to shares of these 3 stocks: AER (+$6.7M), LLY, Accelerate Diagnostic.
- Started 1 new stock position in LLY.
- Reduced shares in these 10 stocks: T, UHAL.B, Valeant Pharmaceuticals Int, DAR, CMS, ABBV, NextEra Energy, KOD, ABT, RLI.
- Sold out of its position in WBD.
- Bruce & Co was a net seller of stock by $-11M.
- Bruce & Co has $311M in assets under management (AUM), dropping by -9.36%.
- Central Index Key (CIK): 0001358331
Tip: Access up to 7 years of quarterly data
Positions held by Bruce & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Bruce & Co
Bruce & Co holds 41 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Uhaul B Common (UHAL.B) | 9.6 | $30M | -7% | 467k | 64.05 |
|
| Allstate Common (ALL) | 8.1 | $25M | 131k | 192.79 |
|
|
| Abbvie Common (ABBV) | 7.8 | $24M | -6% | 138k | 177.70 |
|
| Nextera Energy Common | 7.3 | $23M | -5% | 315k | 71.69 |
|
| Merck Common | 6.8 | $21M | 213k | 99.48 |
|
|
| Duke Energy Common (DUK) | 6.8 | $21M | 196k | 107.74 |
|
|
| CMS Energy Common (CMS) | 6.1 | $19M | -7% | 286k | 66.65 |
|
| At & T Common (T) | 5.7 | $18M | -21% | 773k | 22.77 |
|
| Abbott Common (ABT) | 5.4 | $17M | -2% | 148k | 113.11 |
|
| AerCap Holdings Common (AER) | 4.6 | $14M | +87% | 150k | 95.70 |
|
| XEL Energy Common (XEL) | 4.2 | $13M | 195k | 67.52 |
|
|
| Apple Common (AAPL) | 3.1 | $9.7M | -2% | 39k | 250.42 |
|
| Insteel Common (IIIN) | 3.0 | $9.3M | 343k | 27.01 |
|
|
| Avista Common (AVA) | 2.4 | $7.4M | 202k | 36.63 |
|
|
| Pfizer Common (PFE) | 2.3 | $7.2M | 272k | 26.53 |
|
|
| Bunge Common (BG) | 2.0 | $6.2M | 80k | 77.76 |
|
|
| Uhaul Common (UHAL) | 1.6 | $5.1M | 74k | 69.09 |
|
|
| Archer Daniels Common (ADM) | 1.6 | $5.1M | 100k | 50.52 |
|
|
| Darling Ingredients Common (DAR) | 1.5 | $4.8M | -29% | 141k | 33.69 |
|
| Newmont Common (NEM) | 1.2 | $3.7M | 100k | 37.22 |
|
|
| Vicor Common (VICR) | 1.1 | $3.4M | 70k | 48.32 |
|
|
| Rli Common (RLI) | 1.1 | $3.4M | -8% | 20k | 164.83 |
|
| Kodiak Sciences Common (KOD) | 1.0 | $3.2M | -23% | 323k | 9.95 |
|
| Supernus Common (SUPN) | 1.0 | $3.0M | 82k | 36.16 |
|
|
| Eli Lilly Common (LLY) | 0.5 | $1.5M | NEW | 2.0k | 772.00 |
|
| Personalis Common (PSNL) | 0.5 | $1.5M | -15% | 253k | 5.78 |
|
| Bausch Health Common | 0.4 | $1.4M | -62% | 171k | 8.06 |
|
| Accelerate Diagnostic Cv 5.0% (Principal) | 0.4 | $1.3M | +2% | 3.3M | 0.40 |
|
| XM Sirius Common | 0.4 | $1.3M | 56k | 22.84 |
|
|
| Mannkind Common (MNKD) | 0.4 | $1.3M | 195k | 6.43 |
|
|
| Edap Common (EDAP) | 0.4 | $1.2M | 554k | 2.21 |
|
|
| Ashland Common | 0.3 | $1.1M | 15k | 71.46 |
|
|
| Lava Theraputics Common (LVTX) | 0.2 | $733k | 772k | 0.95 |
|
|
| Viatris Common (VTRS) | 0.2 | $726k | 58k | 12.45 |
|
|
| IGM Bioscience Common (IGMS) | 0.2 | $611k | 100k | 6.11 |
|
|
| Fate Theraputics Common (FATE) | 0.2 | $578k | 350k | 1.65 |
|
|
| Organon Common (OGN) | 0.1 | $466k | 31k | 14.92 |
|
|
| Caribou Biosciences Common (CRBU) | 0.1 | $398k | -16% | 250k | 1.59 |
|
| WEC Energy Common (WEC) | 0.1 | $371k | -12% | 3.9k | 94.04 |
|
| Acorda Theraputics Cv 6.0% (Principal) | 0.1 | $200k | 5.0M | 0.04 |
|
|
| 908 Devices Common (MASS) | 0.0 | $150k | 68k | 2.20 |
|
Past Filings by Bruce & Co
SEC 13F filings are viewable for Bruce & Co going back to 2010
- Bruce & Co 2024 Q4 filed Feb. 11, 2025
- Bruce & Co 2024 Q3 filed Nov. 14, 2024
- Bruce & Co 2024 Q2 filed Aug. 9, 2024
- Bruce & Co 2024 Q1 filed May 13, 2024
- Bruce & Co 2023 Q4 filed Feb. 12, 2024
- Bruce & Co 2023 Q3 filed Nov. 13, 2023
- Bruce & Co 2023 Q2 filed Aug. 8, 2023
- Bruce & Co 2023 Q1 filed May 12, 2023
- Bruce & Co 2022 Q4 filed Feb. 15, 2023
- Bruce & Co 2022 Q3 filed Nov. 15, 2022
- Bruce & Co 2022 Q2 filed Aug. 9, 2022
- Bruce & Co 2022 Q1 filed May 11, 2022
- Bruce & Co 2021 Q4 filed Feb. 16, 2022
- Bruce & Co 2021 Q3 filed Nov. 12, 2021
- Bruce & Co 2021 Q2 filed Aug. 16, 2021
- Bruce & Co 2021 Q1 filed May 17, 2021